Bioactive Adrenomedullin, Organ Support Therapies, and Survival in the Critically Ill: Results from the French and European Outcome Registry in ICU Study
Léa Lemasle(Assistance Publique – Hôpitaux de Paris), Étienne Gayat(Inserm), Oliver Hartmann, Joachim Struck, Ményssa Cherifa(Inserm), Isabelle Rennuit(Hôpital Beaujon), Andreas Bergmann(Agostino Gemelli University Polyclinic), Marie-Céline Fournier(Inserm), Pierre‐François Laterre(Cliniques Universitaires Saint-Luc), Michaël Darmon(Inserm), Xavier Monnet(Bicêtre Hospital), Benjamin Deniau(Inserm), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Alexa Hollinger(University of Basel), Christopher Geven(Radboud University Nijmegen), Alice Blet(Inserm)
Cited by 21
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k